Adali, G. Et Al. 2024. Chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease: Metabolic risk factors are key drivers of hepatocellular carcinoma. Heliyon , vol.10, no.18 .

Adali, G., Aykut, H., Bilgic, N. M., & YILMAZ, Y., (2024). Chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease: Metabolic risk factors are key drivers of hepatocellular carcinoma. Heliyon , vol.10, no.18.

Adali, Gupse Et Al. "Chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease: Metabolic risk factors are key drivers of hepatocellular carcinoma," Heliyon , vol.10, no.18, 2024

Adali, Gupse Et Al. "Chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease: Metabolic risk factors are key drivers of hepatocellular carcinoma." Heliyon , vol.10, no.18, 2024

Adali, G. Et Al. (2024) . "Chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease: Metabolic risk factors are key drivers of hepatocellular carcinoma." Heliyon , vol.10, no.18.

@article{article, author={Gupse Adali Et Al. }, title={Chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease: Metabolic risk factors are key drivers of hepatocellular carcinoma}, journal={Heliyon}, year=2024}